Tempest in a teapot: A systematic review of HPV vaccination and risk compensation research

Human Vaccines and Immunotherapeutics

Volumn 12, Issue 6, 2016, Pages 1435-1450

  Kasting, Monica L ^a   Shapiro, Gilla K ^b,c   Rosberger, Zeev ^b,c   Kahn, Jessica A ^d   Zimet, Gregory D ^e  

^a INDIANA UNIVERSITY   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adolescent; behavior; HPV vaccination; infectious disease; pediatrics; risk compensation; sexual disinhibition

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; CHLAMYDIA TRACHOMATIS; COITUS; CONDOM USE; CONTRACEPTION; HIGH RISK BEHAVIOR; HIV TEST; HUMAN; OUTCOME ASSESSMENT; PAPILLOMAVIRUS INFECTION; PREGNANCY; QUESTIONNAIRE; SCORING SYSTEM; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; SYSTEMATIC REVIEW; VACCINATION; FEMALE; INCIDENCE; MALE; PSYCHOLOGY; SEXUALLY TRANSMITTED DISEASES;

FEMALE; HUMANS; INCIDENCE; MALE; PAPILLOMAVIRUS VACCINES; RISK-TAKING; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; VACCINATION;

EID: 84963547340     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2016.1141158     Document Type: Article

References (65)

1. Centers for Disease Control and Prevention. Genital HPV infection—CDC Fact Sheet. Atlanta, GA, 2014. Retrieved from: http://www.cdc.gov/std/hpv/hpv-factsheet-march-2014.pdf
2. D.Forman, C.de Martel, C.J.Lacey, I.Soerjomataram, J.Lortet-Tieulent, L.Bruni, J.Vignat, J.Ferlay, F.Bray, M.Plummer, Global burden of human papillomavirus and related diseases. Vaccine 2012; 30 Suppl 5:F12–23; PMID:23199955; http://dx.doi.org/10.1016/j.vaccine.2012.07.055
3. Centers for Disease Control Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010; 59:626–9; PMID:20508593.
4. Centers for Disease Control and Prevention. HPV vaccine information for clinicians—Fact sheet. Atlanta, GA 2012. Retrieved from: http://www.cdc.gov/std/hpv/stdfact-hpv-vaccine-hcp.htm
5. United States Food and Drug Administration. FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV. 2014; Retrieved from: http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm426485.htm
6. S.Stokley, J.Jeyarajah, D.Yankey, M.Cano, J.Gee, J.Roark, R.D.Curtis, L.Markowitx. Human papillomavirus vaccination coverage among adolescents, 2007-2013, and post-licensure vaccine safety monitoring, 2006-2014 - United States. MMWR Morb Mortal Wkly Rep. 2014; 63: 620–624; PMID:25055185.
7. J.Wigle, H.Fontenot, G.Zimet. Global delivery of human papillomavirus vaccines. Pediatr Clin North Am 2016; 63:81–95; PMID:26613690; http://dx.doi.org/10.1016/j.pcl.2015.08.004
8. S.Reagan-Steiner, D.Yankey, J.Jeyarajah, L.D.Elam-Evans, J.A.Singleton, C.R.Curtis, J.MacNeil, L.E.Markowitz, S.Stokley. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2014. MMWR Morb Mortal Wkly Rep; 64:784–92; http://dx.doi.org/10.15585/mmwr.mm6429a3
9. United States Department of Health and Human Services. HPV (Human Papillomavirus) vaccine. 2015; Retrieved from: http://www.vaccines.gov/diseases/hpv/
10. A.F.Dempsey, M.M.Davis. Overcoming barriers to adherence to HPV vaccination recommendations. Am J Manag Care 2006; 12:S484–91; PMID:17203992.
11. G.J.Wilde Risk homeostasis theory: an overview. Inj Prev 1998; 4:89–91; PMID:9666358; http://dx.doi.org/10.1136/ip.4.2.89
12. K.Pollitt. Virginity or death! The Nation. New York, NY: Nation Co Inc 33 Irving Place, 8th Floor, New York, NY 10003 USA, 2005.
13. J.R.Guichon, I.Mitchell, P.Buffler, A.Caplan. Citizen intervention in a religious ban on in-school HPV vaccine administration in Calgary, Canada. Prev Med 2013; 57:409–13; PMID:23769899; http://dx.doi.org/10.1016/j.ypmed.2013.06.005
14. HPV vaccine not as effective as abstinence, B.C. bishop tells parents. CBC News. Sep 24, 2015. Retrieved from: http://www.cbc.ca/news/canada/british-columbia/hpv-vaccine-abstinence-bishop-bc-1.3242076
15. R.Smith, D.Motiuk, F.Henry, G.Pettipas, L.Bouchard, M.Chatlain A message to Catholic parents/ guardians and the Catholic educational community 2008. Available:http://ccsdmedia.s3.amazonaws.com/wp-content/uploads/2014/08/Alberta_Bishops_letter.pdf
16. J.Waller, L.A.Marlow, J.Wardle Mothers’ attitudes towards preventing cervical cancer through human papillomavirus vaccination: a qualitative study. Cancer Epidemiol Biomarkers Prev 2006; 15:1257–61; PMID:16835320; http://dx.doi.org/10.1158/1055-9965.EPI-06-0041
17. N.T.Brewer, K.I.Fazekas. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 2007; 45:107–14; PMID:17628649; http://dx.doi.org/10.1016/j.ypmed.2007.05.013
18. A.L.Friedman, H.Shepeard Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV findings from CDC focus group research and implications for practice. Health Educ Behav 2007; 34:471–85; PMID:17000622; http://dx.doi.org/10.1177/1090198106292022
19. E.Olshen, E.R.Woods, S.B.Austin, M.Luskin, H.Bauchner. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health 2005; 37:248–51; PMID:16109349; http://dx.doi.org/10.1016/j. jadohealth.2005.05.016
20. M.A.Habel, N.Liddon, J.E.Stryker. The HPV vaccine: a content analysis of online news stories. J Womens Health 2009; 18:401–7; http://dx.doi.org/10.1089/jwh.2008.0920
21. D.Rosenthal, S.Dyson, M.Pitts, S.Garland. Challenges to accepting a human papilloma virus (HPV) vaccine: a qualitative study of Australian women. Women & Health 2007; 45:59–73; PMID:18019286; http://dx.doi.org/10.1300/J013v45n02_04
22. M.K.Mayer, P.L.Reiter, R.A.Zucker, N.T.Brewer. Parents’ and sons’ beliefs in sexual disinhibition after human papillomavirus vaccination. Sex Transm Dis 2013; 40:822–8; PMID:24275737; http://dx.doi. org/10.1097/OLQ.0000000000000021
23. G.S.Ogilvie, V.P.Remple, F.Marra, S.A.McNeil, M.Naus, K.L.Pielak, T.G.Ehlen, S.R.Dobson, D.M.Money, D.M.Patrick. Parental intention to have daughters receive the human papillomavirus vaccine. Can Med Assoc J 2007; 177:1506–12; http://dx.doi.org/10.1503/cmaj.071022
24. C.L.Schuler, P.L.Reiter, J.S.Smith, N.T.Brewer. Human papillomavirus vaccine and behavioural disinhibition. Sex Transm Infect 2011; 87:349–353; PMID:21357601; http://dx.doi.org/10.1136/sti.2010.048017
25. L.A.V.Marlow, A.S.Forster, J.Wardle, J.Waller. Mothers’ and adolescents’ beliefs about risk compensation following HPV vaccination. J Adolesc Health 2009; 44:446–51; PMID:19380091; http://dx.doi.org/10.1016/j.jadohealth.2008.09.011
26. L.Brabin, S.A.Roberts, R.Stretch, D.Baxter, G.Chambers, H.Kitchener, R.McCann. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ 2008; 336:1056–8; PMID:18436917; http://dx.doi.org/10.1136/bmj.39541.534109.BE
27. D.J.Etter, G.D.Zimet, V.I.Rickert. Human papillomavirus vaccine in adolescent women: a 2012 update. Curr Opin Obstet Gynecol 2012; 24:305–10; PMID:22781077; http://dx.doi.org/10.1097/ GCO.0b013e3283567005
28. J.C.Aujo, S.Bakeera-Kitaka, S.Kiguli, F.Mirembe. No difference in sexual behavior of adolescent girls following Human Papilloma Virus vaccination: a case study two districts in Uganda; Nakasongola and Luwero. BMC Public Health 2014; 14:155; PMID:24520841; http://dx.doi.org/10.1186/1471-2458-14-155
29. E.Marchand, B.Glenn, R.Bastani. HPV vaccination and sexual behavior in a community college sample. J Commun Health 2013; 38:1010–4; http://dx.doi.org/10.1007/s10900-013-9710-0
30. M.Mattebo, N.Grun, A.Rosenblad, M.Larsson, E.Haggstrom-Nordin, T.Dalianis, T.Tyden. Sexual experiences in relation to HPV vaccination status in female high school students in Sweden Eur J Contracept Reprod Health Care 2014; 19:86–92; PMID:24555926; http://dx.doi.org/10.3109/13625187.2013.878021
31. A.Mayhew, T.L.Mullins, L.Ding, S.L.Rosenthal, G.D.Zimet, C.Morrow, J.A.Kahn. Risk perceptions and subsequent sexual behaviors after HPV vaccination in adolescents. Pediatrics 2014; 133:404–11; PMID:24488747; http://dx.doi.org/10.1542/peds.2013-2822
32. T.Mather, K.McCaffery, I.Juraskova. Does HPV vaccination affect women's attitudes to cervical cancer screening and safe sexual behaviour? Vaccine 2012; 30:3196–201; PMID:22425789; http://dx.doi.org/10.1016/j.vaccine.2012.02.081
33. A.M.Ruiz-Sternberg, A.M.Pinzon-Rondon. Risk perception and sexual behavior in HPV-vaccinated and unvaccinated young Colombian women. Int J Gynaecol Obstet 2014; 126:205–8; PMID:24996685; http://dx.doi.org/10.1016/j.ijgo.2014.03.033
34. M.B.Gilkey, T.L.Malo, P.D.Shah, M.E.Hall, N.T.Brewer. Quality of physician communication about Human Papillomavirus vaccine: Findings from a national survey. Cancer Epidemiol Biomarkers Prev 2015; 24:1673–9; PMID:26494764; http://dx.doi.org/10.1158/1055-9965.EPI-15-0326
35. G.D.Zimet, N.W.Stupiansky, T.W.Weiss, S.L.Rosenthal, M.B.Good, M.D.Vichnin. Influence of patient's relationship status and HPV history on physicians’ decisions to recommend HPV vaccination. Vaccine 2011; 29:378–81; PMID:21111781; http://dx.doi.org/10.1016/j.vaccine.2010.11.027
36. D.Kepka, Z.Berkowitz, K.R.Yabroff, K.Roland, M.Saraiya. Human papillomavirus vaccine practices in the USA: do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations? Sex Transm Infect 2012; 88:433–5; PMID:22522751; http://dx.doi.org/10.1136/sextrans-2011-050437
37. A.S.Forster, L.A.Marlow, J.Stephenson, J.Wardle, J.Waller. Human papillomavirus vaccination and sexual behaviour: cross-sectional and longitudinal surveys conducted in England. Vaccine 2012; 30:4939–44; PMID:22664223; http://dx.doi.org/10.1016/j.vaccine.2012.05.053
38. B.T.Hansen, S.K.Kjaer, L.Arnheim-Dahlstrom, K.L.Liaw, K.E.Jensen, L.T.Thomsen, C.Munk, M.Nygard. Human papillomavirus (HPV) vaccination and subsequent sexual behaviour: evidence from a large survey of Nordic women. Vaccine 2014; 32:4945–53; PMID:25045810; http://dx.doi.org/10.1016/j.vaccine.2014.07.025
39. N.C.Liddon, J.S.Leichliter, L.E.Markowitz. Human Papillomavirus vaccine and sexual behavior among adolescent and young women. Am J Prev Med 2012; 42:44–52; PMID:22176845; http://dx.doi.org/10.1016/j.amepre.2011.09.024
40. D.Lutringer-Magnin, J.Kalecinski, C.Cropet, G.Barone, V.Ronin, V.Regnier, Y.Leocmach, A.C.Jacquard, P.Vanhems, F.Chauvin, Prevention of sexually transmitted infections among girls and young women in relation to their HPV vaccination status. Eur J Public Health 2013; 23:1046–53; PMID:23430762; http://dx.doi.org/10.1093/eurpub/ckt018
41. T.Cummings, G.D.Zimet, D.Brown, W.Tu, Z.Yang, J.D.Fortenberry, M.L.Shew. Reduction of HPV infections through vaccination among at-risk urban adolescents. Vaccine 2012; 30:5496–9; PMID:22750043; http://dx.doi.org/10.1016/j.vaccine.2012.06.057
42. W.R.R.Al Romaih, A.Srinivas, S.Shahtahmasebi, H.A.Omar. No significant change in sexual behavior in association with human papillomavirus vaccination in young girls. Int J Child Adolesc Health 2011; 4:351–5.
43. B.Brown, M.M.Blas, O.Heidari, C.Carcamo, N.A.Halsey. Reported changes in sexual behaviour and human papillomavirus knowledge in Peruvian female sex workers following participation in a human papillomavirus vaccine trial. Int J STD AIDS 2013; 24:531–5; PMID:23970767; http://dx.doi.org/10.1177/0956462412473891
44. N.T.Ratanasiripong Human papillomavirus vaccine increases high-risk sexual behaviors: a myth or valid concern. J Sch Nurs 2014; 30:456–63; PMID:24414172; http://dx.doi.org/10.1177/ 1059840513520042
45. M.B.Rysavy, J.D.Kresowik, D.Liu, L.Mains, M.Lessard, G.L.Ryan. Human papillomavirus vaccination and sexual behavior in young women. J Pediatr Adolesc Gynecol 2014; 27:67–71; PMID:24405635; http://dx.doi.org/10.1016/j.jpag.2013.08.009
46. L.Sadler, S.A.Roberts, G.Hampal, D.McManus, D.Mandal, L.Brabin. Comparing risk behaviours of human papillomavirus-vaccinated and non-vaccinated women. J Fam Plann Reprod Health Care 2015; PMID:25605479.
47. K.A.Ports, J.L.Barnack-Tavlaris, M.Mosavel, L.K.Murithi. Young women's sexual and reproductive health post HPV vaccination. Womens Reprod Health 2014; 1:43–55; http://dx.doi.org/10.1080/ 23293691.2014.901804
48. L.Sadler, S.A.Roberts, G.Hampal, D.McManus, D.Mandal, L.Brabin. Comparing risk behaviours of human papillomavirus-vaccinated and non-vaccinated women. J Fam Plann Reprod Health Care 2015; 41:255–8; PMID:25605479; http://dx.doi.org/10.1136/jfprhc-2014-100896
49. R.A.Bednarczyk, R.Davis, K.Ault, W.Orenstein, S.B.Omer. Sexual activity–related outcomes after human papillomavirus vaccination of 11-to 12-year-olds. Pediatrics 2012; 130:798–805; PMID:23071201; http://dx.doi.org/10.1542/peds.2012-1516
50. J.A.Fonseca-Moutinho Smoking and cervical cancer. ISRN obstetrics and gynecology 2011; 2011:847684; PMID:21785734; http://dx.doi.org/10.5402/2011/847684
51. International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer 2004; 83:1–1438.
52. A.B.Jena, D.P.Goldman, S.A.Seabury. Incidence of sexually transmitted infections after human papillomavirus vaccination among adolescent females. JAMA Int Med 2015; 175:617–23; http://dx.doi.org/10.1001/jamainternmed.2014.7886
53. L.M.Smith, J.S.Kaufman, E.C.Strumpf, L.E.Levesque. Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort Study. Can Med Assoc J 2015; 187:E74–81; http://dx.doi.org/10.1503/cmaj.140900
54. J.D.Fortenberry, F.M.Costa, R.Jessor, J.E.Donovan. Contraceptive behavior and adolescent lifestyles: A structural modeling approach. J Res Adolesc 1997; 7:307–29; PMID:12292602; http://dx.doi.org/10.1207/s15327795jra0703_4
55. J.A.Kahn, J.Xu, G.D.Zimet, N.Liu, R.Gonin, M.E.Dillard, K.Squires. Risk perceptions after Human Papillomavirus Vaccination in HIV-infected adolescents and young adult women. J Adolesc Health 2012; 50:464–70; PMID:22525109; http://dx.doi.org/10.1016/j.jadohealth.2011.09.005
56. T.L.Mullins, G.D.Zimet, S.L.Rosenthal, C.Morrow, L.Ding, M.Shew, J.D.Fortenberry, D.I.Bernstein, J.A.Kahn. Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Arch Pediatr Adolesc Med 2012; 166:82–8; PMID:22213755; http://dx.doi.org/10.1001/archpediatrics.2011.186
57. Mullins TLK, L.E.Widdice, S.L.Rosenthal, G.D.Zimet, J.A.Kahn. Risk perceptions, sexual attitudes, and sexual behavior after HPV vaccination in 11–12 year-old girls. Vaccine 2015; 33:3907–12; PMID:26116249; http://dx.doi.org/10.1016/j.vaccine.2015.06.060
58. G.D.Zimet, Z.Rosberger, W.A.Fisher, S.Perez, N.W.Stupiansky. Beliefs, behaviors and HPV vaccine: Correcting the myths and the misinformation. Prev Med 2013; 57:414–8; PMID:23732252; http://dx.doi.org/10.1016/j.ypmed.2013.05.013
59. V.A.Coles, A.S.Patel, F.L.Allen, S.T.Keeping, S.M.Carroll. The association of human papillomavirus vaccination with sexual behaviours and human papillomavirus knowledge: a systematic review. Int J STD AIDS 2014:777–88; PMID:25300588.
60. J.Hunsaker, G.Veselovskiy, J.A.Gazmararian. Health insurance plans and immunization: assessment of practices and policies, 2005-2008. Pediatrics 2009; 124 Suppl 5:S532–9; PMID:19948585; http://dx.doi.org/10.1542/peds.2009-1542M
61. L.E.Markowitz, E.Dunne, M.Saraiya, H.Lawson, H.Chesson, E.Unger. Quadrivalent human papillomavirus vaccine. MMWR Morb Mortal Wkly Rep 2007; 56:1–24; PMID:17218934.
62. D.Moher, A.Liberati, J.Tetzlaff, D.G.Altman. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. J Clin Epidemiol 2009; 62:1006–12; PMID:19631508; http://dx.doi.org/10.1016/j.jclinepi.2009.06.005
63. J.P.Higgins, S.Green. Cochrane handbook for systematic reviews of interventions. Wiley Online Library, 2008.
64. S.West, V.King, T.S.Carey, K.N.Lohr, N.McKoy, S.F.Sutton, L.Lux. Systems to rate the strength of scientific evidence. Evid Rep Technol Assess (Summ) 2002:1–11; PMID:11979732.
65. National Institutes of Health. Quality assessment tool for observational cohort and cross-sectional studies. 2014. Available: https://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascularrisk-reduction/tools/cohort